Canadian Council of the Blind

Toll-Free: 1 877-304-0968

Uncategorized

Luxturna Now Available Through OHIP

Luxturna Now Available Through OHIP The Canadian Council of the Blind (CCB) applauds the Ontario Minister of Health’s announcement on Tuesday, February 28, 2023 that the Novartis treatment Luxturna® is now available through the Ontario public health plan for patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65mutations. Ontario has now joined Quebec, Alberta, and Saskatchewan for public coverage of […]

Luxturna Now Available Through OHIP Read More »

Luxturna Now Available Through OHIP

The Canadian Council of the Blind (CCB) applauds the Ontario Minister of Health’s announcement on Tuesday, February 28, 2023 that the Novartis treatment Luxturna® is now available through the Ontario public health plan for patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65mutations. Ontario has now joined Quebec, Alberta, and Saskatchewan for public coverage of the treatment. Nova Scotia has

Luxturna Now Available Through OHIP Read More »

Scroll to Top
Skip to content